Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Camryn S. Nesiba
Observed name:
Camryn Nesiba
Institutions:
University of Minnesota,
Masonic Cancer Center,
University of Colorado Anschutz
Observed institutions:
University of Minnesota,
The Maria Sklodowska-Curie National Research Institute of Oncology,
Masonic Cancer Center,
University of Colorado Anschutz
ORCID:
0009-0000-1273-590X
Observed ORCID:
0009-0000-1273-590X
OpenAlex ID:
A5115488937
Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
·
Cancer Research
·
7
PDF
CDH1 loss remodels gene expression and lineage identity in human mammary epithelial cells
2026
·
Maggie Musick
, Chinasa A. Ufondu
, et al.
·
PLoS Genetics
·
6
PDF
Supplemental File 2 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 5 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 2 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 4 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 6 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 9 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 3 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 8 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 1 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental File 1 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Data from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Supplemental Figure 7 from Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition
2026
·
Joseph L. Sottnik
, Madeleine T. Shackleford
, et al.
Abstract P5-02-29: Redefining PARP inhibitor paradigms to target DNA repair dysfunction in lobular breast cancer
2025
·
Matthew Sikora
, Joseph L. Sottnik
, et al.
·
Clinical Cancer Research
Targeting DNA Repair Dysfunction in Lobular Breast Cancer by PARP Inhibition
2025
·
Jennifer Diamond
, Camryn Nesiba
, et al.
·
Endocrinology
PDF
Show more works
View as search
Works count:
16
Citation count:
13
H-index:
2
I10-index:
Year
Topic
Type